Prospective study of autoserum for treatment of retinitis pigmentosa

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051004

Enrollment

Unknown

Registered

2021-09-10

Start date

2021-10-05

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis pigmentosa

Interventions

Experimental group:retrobulbar injection of autoserum

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed retinitis pigmentosa; 2. Aged between 18-60 years old; 3. Corrected visual acuity between 0.05-0.5; 4. No other eye diseases.

Exclusion criteria

Exclusion criteria: 1. Vision loss and visual field defect caused by other diseases; 2. Those who have serious chronic diseases and the disease control effect is not good; 3. Those who cannot see a doctor on a regular and long-term basis.

Design outcomes

Primary

Measure	Time frame
best corrected visual acuity;view;color vision;	—

Countries

China

Contacts

Public ContactChen Zhongshan

Taikang Tongji (Wuhan) Hospital

czs1112@163.com+86 18971530008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026